“Frustrated Oligomers” Slow Aggregation of Aβ42
Heterogenous oligomers that include shorter Aβ peptides, such as Aβ37 and Aβ38, along with Aβ42 do not form fibrils, slowing plaque growth.
6538 RESULTS
Sort By:
Heterogenous oligomers that include shorter Aβ peptides, such as Aβ37 and Aβ38, along with Aβ42 do not form fibrils, slowing plaque growth.
A population of AGTR1-expressing dopaminergic neurons in the ventral slice of the human substantia nigra were selectively vulnerable in Parkinson's disease. These cells also expressed the most PD risk genes.
Depleted of cholesterol, neurons laid out the welcome mat for tau aggregates, which readily crossed into the cytosol and seeded aggregation there. Adding cholesterol blocked entry and seeding.
Proteins stuck around longer in the oldest mice. Those involved in neurodegeneration had the most extended lifespans.
When provoked by cytokines, astrocytes change their gene expression so as to make their lysosomes overly alkaline, rendering them dysfunctional. Astrocytes then dump lysosomes' contents outside, creating a neurotoxic culture medium.
While TMEM175 ushers potassium ions out of neutral lysosomes, it shuttles protons out of acidic ones. Sans TMEM175, lysosomes become too “tart,” and stop working. Two papers say so.
Mutations spur fibrillization, while methylation and autophagy keep droplets nice and fluid.
Certain mutations in TDP-43, tau, and NfL add one hydrogen bond to their low-complexity domains. This warps phase transition and strengthens self-aggregation.
In young adults with Down’s, plasma phospho-tau217 correlated with amyloid and tau PET positivity. With great accuracy.
The same endothelial cell response is found in various models of brain disease.
A tetravalent IgG1 prompts TREM2 to cluster, boosting the receptor’s activation 100-fold. Treated mice had fewer plaques, better memories.
The Parkinson’s-related proteins promoted pathological hyperphosphorylation of α-synuclein.
Analysis of 168 metabolites in one blood sample foretold 10-year risk of developing common disorders.
Blocking glycolysis triggers microglia to crank up lipid metabolism, boosting ATP production and improving phagocytosis. In Alzheimer’s disease, the opposite happens.
While GFAP seems a sensitive biomarker of Aβ plaque removal, NfL might respond more slowly.
No filters selected